Concepedia

Author

Piotr Jachimczak

University of Würzburg

Also Known As

Jachimczak, P., P JACHIMCZAK, P Jachimczak, P. Hau, P. Jachimczak, Piotr Jachimczak

52

Publications

1.7K

Citations

15

H-Index

32

Concepts

All Affiliations

University of WürzburgUniversity of RegensburgUniversity of Bayreuth
PJ

About

Piotr Jachimczak is an author at University of Würzburg specializing in medicine, cancer therapeutics, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

142

2

Pathology

3

3

110

3

Health Sciences

2

2

32

4

Biomedical Engineering

1

1

10

5

Neurology

1

1

10

Piotr Jachimczak

×

13

Publications

1.3K

Citations

11

H-Index

YearCitations

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Ulrich Bogdahn, Peter Hau, Günther Stockhammer,

Neuro-Oncology

2010

424

Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies

Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen,

Oligonucleotides

2007

217

Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA

Armin Blesch, Anja‐Katrin Bosserhoff, Rainer Apfel,

PubMed

1994

159

The effect of transforming growth factor-β2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma

Piotr Jachimczak, Ulrich Bogdahn, J. Schneider,

Journal of neurosurgery

1993

147

Transforming growth factor-β-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides

Piotr Jachimczak, Birgit Hessdörfer, Klaus Fabel‐Schulte,

International Journal of Cancer

1996

86

Intracerebral and Intrathecal Infusion of the TGF-β2-Specific Antisense Phosphorothioate Oligonucleotide AP 12009 in Rabbits and Primates: Toxicology and Safety

Reimar Schlingensiepen, Michael Goldbrunner, Mara Szyrach,

Oligonucleotides

2005

68

Vascularization of primary central nervous system tumors: detection with contrast-enhanced transcranial color-coded real-time sonography.

Ulrich Bogdahn, Thomas Fröhlich, Georg Becker,

Radiology

1994

48

The TGF-beta1 antisense oligonucleotide AP 11014 for the treatment of non-small cell lung, colorectal and prostate cancer: Preclinical studies

K.-H. Schlingensiepen, Astrid Bischof, T. Egger,

Journal of Clinical Oncology

2004

31

Ongoing Clinical Trials

Joanna Clarke, Marguerite Ennis, Kathleen R. Lamborn,

Neuro-Oncology

2010

22

Inhibition of immunosuppressive effects of melanoma‐inhibiting activity (MIA) by antisense techniques

Piotr Jachimczak, Rainer Apfel, Anja‐Katrin Bosserhoff,

International Journal of Cancer

2004

17

Page 1